What's new

Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Sun, sitagliptin,metformin hydrochloride, Date of authorisation: 31/03/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Sun, sitagliptin,metformin hydrochloride, Date of authorisation: 31/03/2023, Revision: 2, Status: Authorised

May 6, 2025 - 14:37
 0
Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Sun, sitagliptin,metformin hydrochloride, Date of authorisation: 31/03/2023, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Sun, sitagliptin,metformin hydrochloride, Date of authorisation: 31/03/2023, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Recursion cuts nearly half of its pipeline

Next Article

Stratolaunch Successfully Tests Talon-A2 Completing Reusable Hypersonic Flight a...

Related Posts

Human medicines European public assessment report (EPAR): Vevizye, ciclosporin, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 24, 2025  0

Overview of comments received on guideline on clinical ...

Apr 28, 2025  0

Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 53, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 26, 2025  0